Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
about
Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort StudyRiluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyGenetics Underlying Atypical Parkinsonism and Related Neurodegenerative DisordersParkinsonian syndromesA systematic review of lessons learned from PET molecular imaging research in atypical parkinsonismThe economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United KingdomDisease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus ScaleSocial cognitive deficits and their neural correlates in progressive supranuclear palsy.Progressive supranuclear palsy.Progressive supranuclear palsy misdiagnosed as Parkinson's disease: a case report and review of literature.An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy.Behavioral and neurophysiological effects of transdermal rotigotine in atypical parkinsonism.Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy.Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential iA voxel based comparative analysis using magnetization transfer imaging and T1-weighted magnetic resonance imaging in progressive supranuclear palsy.Atypical parkinsonism: an update.Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective studyAtypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?Emotion recognition in progressive supranuclear palsy.Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.Parkinsonism and tremor disorders. A clinical approach.A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsyTime course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study.Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy.Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments.Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examinationParkinson disease and progressive supranuclear palsy: protein expression in skin.Levodopa responsiveness in disorders with parkinsonism: a review of the literature.Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C.Rapidly progressive dementia.Early-onset dementias: diagnostic and etiological considerations.Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy."Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians.Treatment of progressive supranuclear palsy with autologous adipose tissue-derived mesenchymal stem cells: a case report.Which ante mortem clinical features predict progressive supranuclear palsy pathology?
P2860
Q21131719-FD9C05A7-9E60-48D5-85FF-3C88894805D6Q24655620-23144BB7-7AA3-43B3-927A-0BB9D00DFCABQ26779001-5C5413F4-FE31-422D-8465-1422E3EB7906Q27007524-B5E3CF38-3336-4AA3-8D5C-81CD3FAF814FQ28075227-12353477-080D-4783-B3B5-E072D08F3936Q28740556-F09BB903-7814-4531-84AF-B07E86E11404Q28741794-DD2A5215-6F47-4EE0-BE19-7AE41D51376BQ30466418-FBD49762-D370-4B08-BB25-C8178901675CQ30493367-43179BC2-C253-42DB-B6B1-825B2C8DEE36Q30717977-3F478BBB-608A-4A0A-87A5-82282134D33FQ30828708-99D4A6EE-4D07-40E8-8000-B6944E8FE486Q33180015-9688D591-72BD-4DB2-B3C0-B5836CE2FCC4Q33183516-0AA862C8-750B-47DE-B353-52CAC0DEDC95Q33636262-93EFE00A-BBF0-4CD4-8AB3-DF40E88DCE29Q33713621-0C77069B-C8A4-4C02-BA4D-17527EB2C787Q33734770-9D841877-F803-4E42-8487-BA2522CB47C0Q33778395-0EAB0F98-3A37-4894-9C82-6DD91661EB56Q33877840-7F2D7C90-B9F2-4472-9179-E38E982A799FQ34337714-69390D70-C3A2-464E-87C5-FEA745869B77Q34502926-319C92C3-7858-4974-B679-2528F89A78EBQ34575656-077A0485-AE2C-49E7-87E9-D539CD67C028Q34603131-1D1A3009-6B56-43B9-97F3-DBB704A6E838Q34767058-B2BAE46A-012B-4BA8-9303-5B32D38EF6B6Q34804035-62305B2C-A69E-4955-B393-0CAE5399FD7FQ34994716-555ADC25-89E7-40BE-B728-9A41D6D2528AQ35454079-34DED0AB-7880-49F9-A012-08BB6274EB34Q35459280-599CE340-BFE3-4E78-A5A4-2A026BC3AA33Q35479507-1C1AFCD9-FD57-4898-A1F5-15D095F24A64Q36269614-08688962-7664-41AB-A94A-3151701D0729Q36317742-65C2F4DF-D28B-4F00-93FE-6E46C6235785Q36639646-AA70B803-649E-47D3-87D9-42BC914403E8Q36834251-6809B2B4-40B0-4782-94A4-1AF91A525B8BQ36885378-FBAAAFE2-4D08-4BE3-AFD4-E014AAB17C39Q36894419-239E314B-7E7B-482F-B350-BE0D478BEE79Q37606162-10663C40-7FE6-4F89-A4FA-205F472B78DBQ37621250-7F4538DC-74A0-41A4-A2F3-AF996DA02B47Q38110488-DEC186EE-C83E-4DC1-B478-6E819606018FQ38237228-164423C9-FC1C-403D-8FE9-9737FC2A2C86Q38636874-8E50F2FE-6886-4E99-821D-FF446131FC4EQ38788274-F6B7B38F-46D4-4974-9B5E-6989C050D5DD
P2860
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Natural history of progressive ...... : a clinicopathological study.
@ast
Natural history of progressive ...... : a clinicopathological study.
@en
type
label
Natural history of progressive ...... : a clinicopathological study.
@ast
Natural history of progressive ...... : a clinicopathological study.
@en
prefLabel
Natural history of progressive ...... : a clinicopathological study.
@ast
Natural history of progressive ...... : a clinicopathological study.
@en
P2860
P50
P356
P1476
Natural history of progressive ...... : a clinicopathological study.
@en
P2860
P304
P356
10.1136/JNNP.60.6.615
P4011
1772819e728701f167f5406d022b274e47d281c5
P407
P50
P577
1996-06-01T00:00:00Z